SPDR S&P Biotech ETF Experiences Big Outflow
Dividend Channel Staff - Tuesday, May 7, 10:50 AMSymbols mentioned in this story: XBI, ALPN, RVMD, IBRX Read More »
Revolution Medicines Larger Than S&P 500 Component Bio-Rad Laboratories
Dividend Channel Staff - Wednesday, May 1, 4:35 PMIn the latest look at stocks ordered by largest market capitalization, Russell 3000 component Revolution Medicines Inc (RVMD) was identified as having a larger market cap than the smaller end of the S&P 500, for example Bio-Rad Laboratories Inc (BIO), according to The Online Investor. Click here to find out the top S&P 500 components ordered by average analyst rating » Read More »
XBI, ALPN, RVMD, BMRN: Large Inflows Detected at ETF
Dividend Channel Staff - Monday, April 29, 10:49 AMSymbols mentioned in this story: XBI, ALPN, RVMD, BMRN Read More »
How The Parts Add Up: FNY Targets $78
Dividend Channel Staff - Friday, April 26, 6:43 AMLooking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the First Trust Mid Cap Growth AlphaDEX Fund ETF (FNY), we found that the implied analyst target price for the ETF based upon its underlying holdings is $78.38 per unit. Read More »
Noteworthy ETF Outflows: XBI, ALPN, RVMD, EXAS
Dividend Channel Staff - Friday, April 19, 11:05 AMSymbols mentioned in this story: XBI, ALPN, RVMD, EXAS Read More »
Analysts Expect FTXH To Hit $32
Dividend Channel Staff - Friday, March 15, 6:40 AMLooking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the First Trust Nasdaq Pharmaceuticals ETF (FTXH), we found that the implied analyst target price for the ETF based upon its underlying holdings is $31.80 per unit. Read More »
First Week of September 20th Options Trading For Revolution Medicines (RVMD)
Dividend Channel Staff - Wednesday, February 21, 10:54 AM
Commit To Buy Revolution Medicines At $24, Earn 14.1% Annualized Using Options
Dividend Channel Staff - Tuesday, February 6, 2:22 PM
FTXH's Holdings Imply 12% Gain Potential
Dividend Channel Staff - Thursday, January 11, 6:07 AMLooking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the First Trust Nasdaq Pharmaceuticals ETF (FTXH), we found that the implied analyst target price for the ETF based upon its underlying holdings is $30.66 per unit. Read More »
FYX's Holdings Could Mean 17% Gain Potential
Dividend Channel Staff - Wednesday, November 29, 7:23 AMLooking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the First Trust Small Cap Core AlphaDEX Fund ETF (FYX), we found that the implied analyst target price for the ETF based upon its underlying holdings is $95.18 per unit. Read More »
Commit To Buy Revolution Medicines At $14, Earn 13.3% Annualized Using Options
Dividend Channel Staff - Wednesday, November 8, 1:24 PM
Implied FTXH Analyst Target Price: $32
Dividend Channel Staff - Monday, October 30, 7:17 AMLooking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the First Trust Nasdaq Pharmaceuticals ETF (FTXH), we found that the implied analyst target price for the ETF based upon its underlying holdings is $31.52 per unit. Read More »
Notable Wednesday Option Activity: RVMD, TFC, DGX
Dividend Channel Staff - Wednesday, October 18, 3:29 PM
Revolution Medicines is Now Oversold (RVMD)
Dividend Channel Staff - Monday, October 2, 4:07 PM
Analysts Expect 24% Gains Ahead For FTXH
Dividend Channel Staff - Friday, September 29, 7:38 AMLooking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the First Trust Nasdaq Pharmaceuticals ETF (FTXH), we found that the implied analyst target price for the ETF based upon its underlying holdings is $31.95 per unit. Read More »
Notable ETF Inflow Detected - XBI, BBIO, RVMD, NBIX
Dividend Channel Staff - Friday, September 15, 11:18 AMSymbols mentioned in this story: XBI, BBIO, RVMD, NBIX Read More »
XBI, BBIO, RVMD, NTRA: ETF Outflow Alert
Dividend Channel Staff - Thursday, September 7, 10:53 AMSymbols mentioned in this story: XBI, BBIO, RVMD, NTRA Read More »
XBI, BBIO, HALO, RVMD: Large Outflows Detected at ETF
Dividend Channel Staff - Tuesday, August 8, 11:18 AMSymbols mentioned in this story: XBI, BBIO, HALO, RVMD Read More »
Revolution Medicines Reaches Analyst Target Price
Dividend Channel Staff - Wednesday, August 2, 9:42 AM
Implied FPX Analyst Target Price: $99
Dividend Channel Staff - Tuesday, May 30, 9:53 AMLooking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the First Trust US Equity Opportunities ETF (FPX), we found that the implied analyst target price for the ETF based upon its underlying holdings is $98.76 per unit. Read More »
Monday 3/13 Insider Buying Report: RVMD, WTRG
Dividend Channel Staff - Monday, March 13, 10:48 AMBargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned cash to make a purchase, is that they expect to make money. Today we look at two noteworthy recent insider buys. Read More »
Tuesday 7/26 Insider Buying Report: RVMD, NIC
Dividend Channel Staff - Tuesday, July 26, 10:32 AM Read More »
Tuesday 3/22 Insider Buying Report: PCT, RVMD
Dividend Channel Staff - Tuesday, March 22, 11:13 AM Read More »
Dividend Channel Staff - Tuesday, May 7, 10:50 AMSymbols mentioned in this story: XBI, ALPN, RVMD, IBRX Read More »
Revolution Medicines Larger Than S&P 500 Component Bio-Rad Laboratories
Dividend Channel Staff - Wednesday, May 1, 4:35 PMIn the latest look at stocks ordered by largest market capitalization, Russell 3000 component Revolution Medicines Inc (RVMD) was identified as having a larger market cap than the smaller end of the S&P 500, for example Bio-Rad Laboratories Inc (BIO), according to The Online Investor. Click here to find out the top S&P 500 components ordered by average analyst rating » Read More »
XBI, ALPN, RVMD, BMRN: Large Inflows Detected at ETF
Dividend Channel Staff - Monday, April 29, 10:49 AMSymbols mentioned in this story: XBI, ALPN, RVMD, BMRN Read More »
How The Parts Add Up: FNY Targets $78
Dividend Channel Staff - Friday, April 26, 6:43 AMLooking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the First Trust Mid Cap Growth AlphaDEX Fund ETF (FNY), we found that the implied analyst target price for the ETF based upon its underlying holdings is $78.38 per unit. Read More »
Noteworthy ETF Outflows: XBI, ALPN, RVMD, EXAS
Dividend Channel Staff - Friday, April 19, 11:05 AMSymbols mentioned in this story: XBI, ALPN, RVMD, EXAS Read More »
Analysts Expect FTXH To Hit $32
Dividend Channel Staff - Friday, March 15, 6:40 AMLooking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the First Trust Nasdaq Pharmaceuticals ETF (FTXH), we found that the implied analyst target price for the ETF based upon its underlying holdings is $31.80 per unit. Read More »
First Week of September 20th Options Trading For Revolution Medicines (RVMD)
Dividend Channel Staff - Wednesday, February 21, 10:54 AM
Commit To Buy Revolution Medicines At $24, Earn 14.1% Annualized Using Options
Dividend Channel Staff - Tuesday, February 6, 2:22 PM
FTXH's Holdings Imply 12% Gain Potential
Dividend Channel Staff - Thursday, January 11, 6:07 AMLooking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the First Trust Nasdaq Pharmaceuticals ETF (FTXH), we found that the implied analyst target price for the ETF based upon its underlying holdings is $30.66 per unit. Read More »
FYX's Holdings Could Mean 17% Gain Potential
Dividend Channel Staff - Wednesday, November 29, 7:23 AMLooking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the First Trust Small Cap Core AlphaDEX Fund ETF (FYX), we found that the implied analyst target price for the ETF based upon its underlying holdings is $95.18 per unit. Read More »
Commit To Buy Revolution Medicines At $14, Earn 13.3% Annualized Using Options
Dividend Channel Staff - Wednesday, November 8, 1:24 PM
Implied FTXH Analyst Target Price: $32
Dividend Channel Staff - Monday, October 30, 7:17 AMLooking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the First Trust Nasdaq Pharmaceuticals ETF (FTXH), we found that the implied analyst target price for the ETF based upon its underlying holdings is $31.52 per unit. Read More »
Notable Wednesday Option Activity: RVMD, TFC, DGX
Dividend Channel Staff - Wednesday, October 18, 3:29 PM
Revolution Medicines is Now Oversold (RVMD)
Dividend Channel Staff - Monday, October 2, 4:07 PM
Analysts Expect 24% Gains Ahead For FTXH
Dividend Channel Staff - Friday, September 29, 7:38 AMLooking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the First Trust Nasdaq Pharmaceuticals ETF (FTXH), we found that the implied analyst target price for the ETF based upon its underlying holdings is $31.95 per unit. Read More »
Notable ETF Inflow Detected - XBI, BBIO, RVMD, NBIX
Dividend Channel Staff - Friday, September 15, 11:18 AMSymbols mentioned in this story: XBI, BBIO, RVMD, NBIX Read More »
XBI, BBIO, RVMD, NTRA: ETF Outflow Alert
Dividend Channel Staff - Thursday, September 7, 10:53 AMSymbols mentioned in this story: XBI, BBIO, RVMD, NTRA Read More »
XBI, BBIO, HALO, RVMD: Large Outflows Detected at ETF
Dividend Channel Staff - Tuesday, August 8, 11:18 AMSymbols mentioned in this story: XBI, BBIO, HALO, RVMD Read More »
Revolution Medicines Reaches Analyst Target Price
Dividend Channel Staff - Wednesday, August 2, 9:42 AM
Implied FPX Analyst Target Price: $99
Dividend Channel Staff - Tuesday, May 30, 9:53 AMLooking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the First Trust US Equity Opportunities ETF (FPX), we found that the implied analyst target price for the ETF based upon its underlying holdings is $98.76 per unit. Read More »
Monday 3/13 Insider Buying Report: RVMD, WTRG
Dividend Channel Staff - Monday, March 13, 10:48 AMBargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned cash to make a purchase, is that they expect to make money. Today we look at two noteworthy recent insider buys. Read More »
Tuesday 7/26 Insider Buying Report: RVMD, NIC
Dividend Channel Staff - Tuesday, July 26, 10:32 AM Read More »
Tuesday 3/22 Insider Buying Report: PCT, RVMD
Dividend Channel Staff - Tuesday, March 22, 11:13 AM Read More »
|
A Brief Dividend History Top Dividends Opting for the Cash Dividend What is a Dividend? Dividend Calculator Dividend Yield Traps to Avoid Dividend Paying Stocks High Yield Stocks Paying Monthly Dividend Stocks: Their Importance Dividend ETFs High Dividend Stocks Paying Quarterly Dividend Aristocrats List Top Dividend Stocks YTD
Other news: News from PR Newswire |
|